Navigation Links
Intelligent Design Book Delivers Blow to Darwin
Date:11/17/2009

CRACKS AMAZON.COM BEST SELLER LIST IN SCIENCE

Signature in the Cell makes 2009 list of top ten best selling science books

SEATTLE, Nov. 17 /PRNewswire-USNewswire/ -- Despite Darwinists' attempts to suppress the debate over evolution, a new book about the controversial theory of intelligent design made Amazon.com's list of the year's Top 10 bestselling books in science, just as the world marks 150 years since Charles Darwin published his own theory in his landmark book On the Origin of Species.

Signature in the Cell: DNA and the Evidence for Intelligent Design (HarperOne) by Dr. Stephen C. Meyer is entering its fifth printing in as many months, and continues to sell strongly both online and in stores, according to the publisher. According to Amazon.com, books on its 2009 list of best sellers are "[r]anked according to customer orders through October. Only books published for the first time in 2009 are eligible."

"Darwin is mistakenly thought to have killed the design argument in science," said Robert Crowther, director of communications at Discovery Institute's Center for Science and Culture, which is the intelligent design research program directed by Dr. Meyer. "Now, here's a book about the science of intelligent design that shows how the design argument is being revived with powerful new arguments relevant to our culture."

By using the same method of reasoning that Darwin himself used, Dr. Meyer explains how intelligent design can be formulated as a rigorous scientific argument. In Signature in the Cell Dr. Meyer shows that the digital code imbedded in DNA points powerfully to a designing intelligence and helps unravel a mystery that Darwin did not address: how did the very first life begin?

www.discovery.org/csc

www.amazon.com

SOURCE Discovery Institute


'/>"/>
SOURCE Discovery Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29
2. UK scientists developing intelligent harvesting robot to save farms up to 100,000 a year
3. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
4. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
5. Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
6. AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
7. CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
8. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
9. Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
10. TCT 2009 to Feature vProtect(TM) Luminal Shield, a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical
11. AEterna Zentaris Partner, Keryx Biopharmaceuticals, Receives Orphan-Drug Designation for Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... United States multicenter, prospective clinical study that demonstrates the accuracy of the ... of identifying clinically significant acute bacterial and viral respiratory tract infections by ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
Breaking Biology Technology:
(Date:8/15/2017)...   ivWatch LLC , a medical device company focused on ... receipt of its ISO 13485 Certification, the global standard for medical ... Standardization (ISO®). ... Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as ...
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
Breaking Biology News(10 mins):